Meditech innovation acceleration

13 June 2017

The Medical Device Commercialisation Training Program (MDCPT) bridges the gap between the development of medical devices and their commercialisation. Tegan Cheng, manager of the EPIC 3D Orthopaedic Lab,   was selected to join this 12 week course where ground breaking meditech innovations are accelerated.

Cicada Innovations, Australia’s only ‘super incubator’ delivers the program in conjunction with NSW Office for Health and Global Research.

Tegan was awarded an International Engagement Fellowship at the MDCTP Showcase by the NSW Minister for Health, Brad Hazzard. The Fellowship will enable Tegan to travel internationally to validate the business model in overseas markets.

The innovation is an orthopaedic implant that will radically change the treatment for children with bone deformities of the lower limbs, developed at Kids Research Institute. Currently available treatment requires surgery and a frame and is very intensive over at least six months.  The implant needs only minimally invasive surgery and will correct deformities as bones grow straight over time.

The 18 participants split into teams. Each team chose one device and   consulted stakeholders about the currently available technology and the potential of the new technology.  “The course covered a range of areas, such as how to set up a company and how to pitch, especially to investors” said Tegan.” We learnt about raising capital, IP and negotiation. It was such a valuable experience.”

The EPIC 3D Orthopaedic Lab engineers and prototypes implants for children using 3D design and printing to better address individual health needs. A multi-disciplinary team of surgeons, engineers, biomedical scientists and allied professionals work on the design and development.

  • Share Story: